Please complete the CAPTCHA to continue
@immunoscape.com
✓
2 phones found area 201
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Christopher Alfonso is listed as Immunology | Business Development | External Innovation | Scientific Affairs at ImmunoScape, based in San Diego, California, United States. AeroLeads shows a work email signal at immunoscape.com, phone signal with area code 201, and a matched LinkedIn profile for Christopher Alfonso.
Christopher Alfonso previously worked as Senior Director, Business Development at Immunoscape and Director, Business Development at Immunoscape. Christopher Alfonso holds Doctor Of Philosophy (Ph.D.), Immunology from Newcastle University.
This section adds company-level context without repeating Christopher Alfonso's masked contact details.
AeroLeads found 1 current-domain work email signal for Christopher Alfonso. Compare company email patterns before reaching out.
Innovative PhD MBA Immunologist from pharmaceutical, biotechnology, medical device and academic research organizations. Strategic and critical thinker, advancing therapeutic discovery & development through scientific know-how and strategic alliances.
Listed skills include Immunology, Flow Cytometry, Cell Culture, Biotechnology, and 29 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Singapore, Sg
MiNK Therapeuticshttps://www.biospace.com/article/releases/immunoscape-andmink-therapeutics-collaborate-to-accelerate-novel-tcridentification-and-therapeutic-development/EDDChttps://finance.yahoo.com/news/immunoscape-partners-singapore-experimental-drug-140000979.html
Singapore, Sg
Pure MHChttps://immunoscape.com/immunoscape-inks-licensing-deal-with-pure-mhc-to-advance-development-of-novel-tcr-based-therapies/
Lexington, Massachusetts, Us
• KOL engagement & alliance development for pre-clinical & clinical programs.• Hypotheses, insights & value-driver generation for business development of emerging science for discovery target selection and lifecycle asset extension.• Program management for company-sponsored research.
• Strategic planning, budgeting and CMC tech transfer for CAR-NK cell therapy development.• IND-enabling program management.• S&E for process expansion & fill/finish technologies streamlining clinical operations.
Franklin Lakes, New Jersey, Us
Built and led innovative industry-academic alliance via KOL engagement, scientific outreach and co-creation for key business objectives and company-wide strategic support.Integrated industry technologies into non-traditional academic arena generating new revenue streams.Successful partnering for external funding opportunities including a ~$14m NIH-NIMH NCRCRG award.External scientific advisor at collaborator sites sourcing R&D collaborations and guiding phenotypic drug screening and biomarker signature discovery.Target selection and asset in-licensing go/no-go decision team.Scouted and evaluated evidence-based targets, technologies and competitive intelligence supplying research and clinical mAb portfolio.
La Jolla, California, Us
• Immunomodulation via sphingosine 1-phosphate (S1P) receptors with small molecule agonists, in vivo pharmacology, high resolution methodologies and collaborations.Alfonso C, et al. Eur. J. Immunol. (2006) 36, 149-159 Sanna MG, et al. J. Biol. Chem. (2004) 279, 13839-13848Ait-Azzouzene D, et al. Immunol. Rev. (2004) 200, 272.Rosen H, et al. Immunol. Rev. (2003) 195, 160-177 Rosen H, et al. Proc. Natl. Acad. Sci. (2003) 100, 10907-10912
New Brunswick, Nj, Us
• Target discovery and characterization.• Ag-specific T cell discovery and secondary cell-based assay development.• Expanded internal discovery capabilities and scientific field advancement through external collaboration with non-commercial pharma tools cited in 20 publications.US 6372955 B1. Methods for producing B cells and antibodies from H2-O modified transgenic miceL Karlsson, W-P Leung, PA Peterson, C Alfonso.Ortho McNeil Pharmaceutical, Inc. Issued 4/16/2002Alfonso C, et al. J. Immunol. (2003) 171, 2331-2337 Alfonso C, et al. Eur. J. Immunol. (2003) 33, 2014-2021 Pluger EBE, et al. Eur. J. Immunol. (2002) 32, 467-476 Alfonso C, et al. J. Immunol. (2001) 167, 6348-6355 Maric M, et al. Science (2001) 294, 1361-1365Alfonso C and L Karlsson. Annu. Rev. Immunol. (2000) 18, 113-142Alfonso C, et al. Immunol. Rev. (1999) 172, 255-266Generated MHC II antigen-specific T-cell hybridomas, shared & utilized across the scientific community,W. Qi et al. J. Am. Chem. Sci. (2018) 140, 8851-8857.T. Zhao et al. Lab. Invest. (2017) 97, 764-771E.R.O. Allan et al. J. Immunol. (2014) 192, 4989-5001R Ishikawa et al. Int. Immunol. (2014) 26, 283-289Y. Li et al. Int. Immunol. (2012) 24, 751-758L.J. Young et al. Nat. Immunol. (2008) 9, 1244-1252K.T. Hastings et al. J. Immunol. (2006) 177, 8569-8577C. Ramsey et al. Eur. J. Immunol. (2006) 36, 305-317X. Chen et al. J. Immunol. (2006) 76, 3548-3556N.D. Huntington et al. Nat. Immunol. (2005) 7, 190-198K. Honey et al. J. Immunol. 172, (2004) 4142-4150N.S. Wilson et al. Blood 103, (2004) 2187-2195D. El-Sukkari et al. J. Immunol. (2003) 171, 5003-5011C-S. Hsieh et al. J. Immunol. (2002) 168, 2618-2625M. Boes et al. Nature (2002) 418, 923-924
Quick answers generated from the profile data available on this page.
Christopher Alfonso works for ImmunoScape.
Christopher Alfonso is listed as Immunology | Business Development | External Innovation | Scientific Affairs at ImmunoScape.
AeroLeads has found 1 work email signal at @immunoscape.com for Christopher Alfonso at ImmunoScape.
AeroLeads has found 2 phone signal(s) with area code 201 for Christopher Alfonso at ImmunoScape.
Christopher Alfonso is based in San Diego, California, United States while working with ImmunoScape.
Christopher Alfonso has worked for Immunoscape, Kiniksa Pharmaceuticals, Nantkwest, Consultancy, and Bd Biosciences.
You can use AeroLeads to view verified contact signals for Christopher Alfonso at ImmunoScape, including work email, phone, and LinkedIn data when available.
Christopher Alfonso holds Doctor Of Philosophy (Ph.D.), Immunology from Newcastle University.
Christopher Alfonso is listed with skills including Immunology, Flow Cytometry, Cell Culture, Biotechnology, Molecular Biology, Cell Biology, Pcr, and Life Sciences.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts